Sagimet Biosciences Inc.

About Sagimet Biosciences Inc.

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel fatty acid synthase (FASN) inhibitors to treat dysfunctional metabolic and fibrotic pathways in diseases caused by the overproduction of the fatty acid palmitate. Their mission includes exploring the use of FASN inhibitors in areas such as metabolic dysfunction-associated steatohepatitis (MASH), acne, and select forms of cancer.

Products & Services

Denifanstat:An oral, once-daily selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). It has completed Phase 2 trials (FASCINATE-1 and FASCINATE-2) and received Breakthrough Therapy designation by the FDA for non-cirrhotic MASH with moderate to advanced liver fibrosis (F2-F3 stages).

TVB-3567:A pipeline FASN inhibitor candidate under development for dermatology (acne) and oncology (solid tumors).

Specialties

Fatty Acid Synthase (FASN) Inhibitors Metabolic Dysfunction-Associated Steatohepatitis (MASH) Acne Treatment Oncology (Solid Tumors)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering of Series A Common Stock T: - FT: Public Offering of Series A Common Stock	A: 112500000 MR: - FA: $112.5 million FAN: 112500000	D: 2024-01-25 FD: 2024-01-25	4 investors
2	RT: IPO T: - FT: IPO	A: 96400000 MR: - FA: 96.4 million USD FAN: 96400000	D: 2023-08-15 FD: 2023-08-15	4 investors

Public Offering of Series A Common Stock Latest

2024-01-25

$112.5M

4 investors (Pro only)

IPO 2023-08-15

$96.4M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

G

George Kemble

Chair

D

David Happel

Chief Executive Officer & Director

A

Anne Phillips

B

Beth Seidenberg

Lead Independent Director

E

Elizabeth Grammer

Chief Legal and Administrative Officer

J

Jennifer Jarrett

Chief Operating Officer

View 10 more team members with Pro

Unlock Full Team Directory

Recent News